THDB(SH:600867) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-11-02 14:28Core Viewpoint - The controlling shareholder, Dongbao Group, has announced a share buyback plan for Tonghua Dongbao Pharmaceutical Co., Ltd., expressing confidence in the company's future development and value recognition [1][2]. Summary by Sections Share Buyback Plan - Dongbao Group plans to increase its shareholding in Tonghua Dongbao starting from October 31, 2024, through centralized bidding on the Shanghai Stock Exchange, with a minimum increase of 1% of the total share capital (19,817,341 shares) and a maximum of 2% (39,634,681 shares) [1]. - The implementation period for the buyback plan is from October 31, 2024, to October 30, 2025, without a set price range, depending on stock price fluctuations and overall market trends [1]. Implementation Results - As of October 30, 2025, Dongbao Group has successfully increased its shareholding by 27,801,409 shares, amounting to 228 million yuan, which represents 1.42% of the current total share capital [2]. - The actual increase has exceeded the lower limit of the buyback plan [2]. Additional Information - The buyback plan complies with relevant laws and regulations, including the Securities Law and the Shanghai Stock Exchange listing rules [3]. - The implementation of this buyback plan will not affect the company's shareholding structure or lead to changes in the controlling shareholder [4].